1Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein(LDL)subfractions:relative contribution of small, dense LDL to coronar heart disease risk. Atherosclerosis 1994; 106(2) :41 - 253.
2Turner RC, Millins H, Neil HAW, et al. Risk factor for coronary artery disease in non - insulin dependent diabetes mellitus: United Kingdom prospective diabetes study ( UKPDS: 23 ) BMJ 1998; 316:823 - 828.
3Colhon HM, Thomason MJ, Mackness MI, et al. Design of the Collaborstive AtoRvastatin Diabetes Study(CARDS)in patients with Type 2 diabetes. Diabet Med 2002; 19:201 - 211.
4Colhon HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastain in type 2 diabetes in the Collaborstive AtoRvastatin Diabetes Study(CARDS):A multicentre randomised placebo - controlled trial. Lancet 2004; 364: 685 - 696.
5Haffner SM: American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004 ;27 Suppl 1: S68-71.
6De Backer G, Ambrosioni E, Borch - Johnsen K, et al. Executive Summary. European guideline on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003 ;24:1601 - 1610.
7Grundy SM, Cleeman JI, Merz NB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines. Circulation 2004; 110; 227 - 239.
